Mai Sato et al.
Oncotarget, 6(5), 3292-3305 (2015-02-12)
MYC deregulation is a driver of many human cancers. Altering the balance of MYC protein levels at the level of transcription, protein stability, or turnover is sufficient to transform cells to a tumorigenic phenotype. While direct targeting of MYC is